Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Ogrodnik

Plastic and Reconstructive Surgery Maywood, IL Medical Doctor

NPI 1831417732 CMS profile 1343356

2160 S 1St Ave, Maywood, IL 60153

Open in the dashboard

General payments

$5,838

66 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Ogrodnik of Maywood, IL is reported in the CMS Open Payments database as having received $5,838 across 66 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,142 16
2024 General $1,202 17
2023 General $1,050 10
2022 General $644 5
2021 General $409 7
2020 General $128 1
2019 General $1,263 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Ogrodnik
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Joseph Ogrodnik were reported at $1,142. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Joseph Ogrodnik Plastic and Reconstructive Surgery median Middle half National median
2019 $1,263 $335 $121–$1,264 $163
2020 $128 $162 $57–$417 $114
2021 $409 $245 $89–$735 $132
2022 $644 $325 $120–$932 $149
2023 $1,050 $343 $129–$999 $160
2024 $1,202 $390 $141–$1,085 $164
2025 $1,142 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Integra LifeSciences Corporation $735 5 payments
  2. Mentor Worldwide LLC $727 12 payments
  3. AxoGen $611 3 payments
  4. PolyNovo North America LLC $542 9 payments
  5. AbbVie, Inc. $291 4 payments
  6. Musculoskeletal Transplant Foundation Inc. $285 2 payments
  7. Checkpoint Surgical, Inc $280 4 payments
  8. Solventum Corporation $252 3 payments
  9. KCI USA, Inc $198 4 payments
  10. Tactile Systems Technology Inc $185 2 payments
  11. Other $1,731 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,838 66 payments
Products named General payments · program years 2019–2025
  1. MENTOR MemoryGel Resterilizable Gel Sizer $619 10 payments
  2. AxoGuard Nerve Connector $611 3 payments
  3. AXOGUARD NERVE PROTECTOR $611 3 payments
  4. Integra Recon-Skin And Wound $477 3 payments
  5. Integra Recon-Skin And Wound $477 3 payments
  6. INTEGRA DERMAL REGENERATION TEMPLATE $477 3 payments
  7. PREVENA $355 6 payments
  8. NOVOSORB BTM $320 7 payments
  9. V.A.C. VERAFLO CLEANSE CHOICE $311 3 payments
  10. Integra Recon-Skin And Wound $310 2 payments
  11. Other $6,168 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 74 billing codes

Paid by Medicare

$33,282

Medicare's payments for the services billed

Medicare patients

95

Average age 67

Services billed

241

61 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 48%
Diabetes 39%
Ischemic heart disease 39%
Chronic kidney disease 32%
Atrial fibrillation 28%
Depression 28%
Heart failure 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

66 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record